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The mechanisms underlying the silencing of alterna-
tive fate potentials in very early B cell precursors
remain unclear. Using gain- and loss-of-function
approaches together with a synthetic Zinc-finger
polypeptide (6ZFP) engineered to prevent transcrip-
tion factor binding to a defined cis element, we
show that the transcription factor EBF1 promotes
B cell lineage commitment by directly repressing
expression of the T-cell-lineage-requisite Gata3
gene. Ebf1-deficient lymphoid progenitors exhibited
increased T cell lineage potential and elevated Gata3
transcript expression, whereas enforced EBF1
expression inhibited T cell differentiation and caused
rapid loss of Gata3 mRNA. Notably, 6ZFP-mediated
perturbation of EBF1 binding to a Gata3 regulatory
region restored Gata3 expression, abrogated EBF1-
driven suppression of T cell differentiation, and pre-
vented B cell differentiation via a GATA3-dependent
mechanism. Furthermore, EBF1 binding to Gata3
regulatory sites induced repressive histone modifi-
cations across this region. These data identify a
transcriptional circuit critical for B cell lineage
commitment.
INTRODUCTION
The development of multicellular systems requires that multipo-
tent progenitors differentiate into specialized lineage-restricted
daughter cells. The adoption of a particular cell fate by multipo-
tent cells is orchestrated by networks of transcription factors,
which act to coordinate changes in gene expression commensu-
rate with the ultimate function of the cell fate in question.
Commitment of multipotent cells to a particular lineage often re-
quires the silencing of gene products that are incompatible with
the function of end-product cells. For instance, during hemato-
poiesis, erythroid and myeloid lineage genes are silenced during
the generation of lymphocyte-biased progenitors (Miyamoto
et al., 2002) and B cell and myeloid-affiliated genes are actively
repressed in early T lineage cells (Yang et al., 2010; Zhang
et al., 2012). Understanding the regulation of cell fate decisions
in hematopoiesis should provide insights into the development930 Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc.of a wide array of multicellular systems and lead to strategies
to enhance or limit the generation of particular cell types.
Early B cell development is regulated by several transcription
factors. These include Ikaros and PU.1, which promote the
generation of lymphoid-biased precursors, and early B cell
factor-1 (EBF1), Pax5, and the E2a isoforms E12 and E47
(encoded by the Tcf3 locus), which coordinate the differentiation
of lymphoid progenitors into lineage-restricted pro-B cells
(reviewed in Mandel and Grosschedl, 2010). Given that each of
these factors is essential for generating B cell lineage precursors,
much work has been devoted to identifying regulated and
coregulated target genes. Ebf1, Pax5, and Tcf3 gene products
synergize to activate the expression of the pre-BCR components
l5 and VpreB and the B cell signaling protein Ig-a (encoded by
Igll1, Vpreb1, and Cd79a, respectively) (reviewed in Busslinger,
2004; Hagman and Lukin, 2006). Notably, Pax5, Ebf1, and Tcf3
gene products are each proposed to suppress differentiation
of alternative fates (Ikawa et al., 2004; Nutt et al., 1999; Pongu-
bala et al., 2008). In this regard, Pax5 is regarded as the domi-
nant determinant of B cell commitment, because deletion of
Pax5 in pro-B cells or mature peripheral B cells allows these cells
to adopt alternative fates (Cobaleda et al., 2007; Mikkola et al.,
2002). A key but unresolved question is whether E12 and E47
and/or EBF1 promote B cell lineage restriction by collaborating
with Pax5 or whether these factors are components of distinct
transcriptional circuits important for acquiring and perhaps
maintaining B cell identity.
In the thymus, the T cell program is initiated when the earliest
defined T cell precursors (ETPs) encounter ligands for the Notch
receptor family (Sambandam et al., 2005). Stimulation of Notch1
on ETPs by the Notch ligand delta-like-4 (DL4) promotes the
expression of T-cell-affiliated transcription factors including
TCF1 (encoded by Tcf7), which in turn promotes the expression
of many genes required for T cell function (Weber et al., 2011).
However, early T cell development is also controlled by the
zinc finger transcription factor GATA3. Indeed, GATA3 is essen-
tial for very early T cell development in the thymus beginning at
the ETP stage (Hendriks et al., 1999; Taghon et al., 2007), and
optimal Notch1 expression may require GATA3 (Wei et al.,
2011). Suppression of the T cell fate in B cells is thought to occur
through the Pax5-driven repression of Notch1 (Souabni et al.,
2002). However, we showed previously that EBF1 prevents
myeloid and T cell differentiation when introduced into Pax5/
progenitors (Pongubala et al., 2008). The latter observation sug-
gests that Pax5-independent transcriptional pathways may also
regulate B cell lineage restriction, while also raising questions
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Figure 1. Ebf1-Deficient B-Cell-Lineage-Biased Precursors
Possess Increased T Lymphoid Potential
(A) BM cells from chimeras reconstituted with B6 or B6.Ebf1/ fetal liver
12 weeks previously were stained with antibodies to the host-specific deter-
minant CD45SJL and the antibodies shown in Figure S1. 2 3 106 events were
collected on an LSR2 flow cytometer and gated as in Figure S1.
(B) 200 WT or Ebf1/ B220+Ly6D or B220Ly6D+ cells derived from the
indicated chimeras were sorted onto pre-established OP9-DL4 cells sup-
plemented with IL-7, FL, and SCF. Seven days later, cells were counted and
analyzed for cell surface marker expression. The mean number of viable
(DAPI) CD45+ early T cell lineage (Thy1.2+CD25+) cells in triplicate cultures is
shown. Error bars indicate SEMs, *p < 0.005. Data are representative of three
separate experiments.
(C) 96 singleWT orEbf1/B220+Ly6D or B220+Ly6D+ cells were sorted onto
pre-established OP9-DL4 cells in flat-bottom 96-well plates with IL-7, FL, and
SCF. Wells containing cell growth were counted and analyzed on day 10. Data
are representative of two separate experiments. See also Figure S1.
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Regulation of B Cell Lineage Commitmentabout the mechanism(s) employed by EBF1 to constrain T cell
differentiation.
Here, we utilize a series of gain- and loss-of-function
approaches to uncover the transcriptional mechanism under-
pinning EBF1-mediated suppression of T cell development.
Our findings indicate that EBF1 limits early T cell differentiation
by directly repressing Gata3 transcription and suggest that
EBF1 silences Gata3 expression by promoting repressive
histone modifications across Gata3 regulatory regions. These
data identify a transcriptional circuit critical for preventing
T cell differentiation and adopting the B cell fate.
RESULTS
EBF1 Suppresses T Cell Differentiation in
B-Cell-Lineage-Biased Lymphoid Progenitors
Lymphoid-biased progenitors in the bone marrow (BM), also
referred to as common lymphoid progenitors (CLPs) (Kondo
et al., 1997), can be subdivided into several subpopulations.
More mature B-cell-lineage-biased progenitors within this het-
erogeneous population are also termed pre-pro-B cells and are
characterized by progressive loss of T cell potential coincident
with expression of the surface proteins B220 and/or Ly6D (Inlay
et al., 2009; Rumfelt et al., 2006). Other researchers have
employed a l5 transgene to mark B-cell-lineage-biased pre-
cursors in these pools (Mansson et al., 2008). Given the rarity
of these cells (less than 0.2% of all BM cells) and the diverse
approaches used to resolve these populations, we developed
a flow cytometric strategy based on differential surface ex-
pression of B220 and Ly6D on lymphoid-biased progenitors
defined previously as Lineage(Lin)CD19IL-7Ra+Flt3+Sca1lo
c-Kitlo (Allman et al., 2003). With this approach we resolved three
populations of IL-7Ra+Flt3+Sca1loc-Kitlo cells defined as
B220Ly6D, B220+Ly6D, and B220+Ly6D+ in both wild-type
and Ebf1/ mice (Figure 1A and Figure S1A available online).
Consistent with past work (Rumfelt et al., 2006), coexpression
of B220 and Ly6D correlated with increased Ebf1, Pax5, and
Rag1 expression (Figure S1B), and when sorted from wild-type
mice, the B220+Ly6D+ subset possessed fewer cells with T cell
lineage potential (Figure 1B; Inlay et al., 2009; Rumfelt et al.,
2006). Notably, however, although Ebf1/ B220+Ly6D+ precur-
sors were not substantially altered in number or phenotype
compared to their wild-type counterparts (Figure 1A), they ex-
hibited increased T cell lineage potential in both bulk and
single-cell cultures (Figures 1B and 1C). These data extend
past analyses (Zandi et al., 2008) by showing that EBF1 con-
strains T cell potential as B-cell-lineage-biased B220+Ly6D+ pro-
genitors give rise to B-cell-lineage-restricted precursors.
EBF1 Overrides Overt T Cell Induction by Notch1 and
TCF1
To test directly whether EBF1 prevents very early T cell differen-
tiation independently of Pax5, we sorted BM progenitors from
Pax5/ fetal liver, transduced these cells with control or
EBF1-expressing retrovirus, and then resorted transduced
(GFP+) cells onto OP9-DL4 stromal cells. As shown (Figure 2A),
despite stimulation with DL4, upon enforced EBF1 expression,
Pax5/ progenitors generated substantially fewer T lineage
cells compared to controls. Enforcing EBF1 expression alsoImmunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc. 931
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Figure 2. Notch1 and TCF1 Fail to Prevent Inhibition of Early T Cell Lineage Differentiation by EBF1
(A) LSK (LinSca1+c-kit+) cells were sorted from e14.5 Pax5/ fetal livers and transduced with control MigR1 or MigR-EBF1 virus. Viable GFP+ cells were sorted
24 hr after transduction onto pre-established OP9-DL4 cells with IL-7, FL, and SCF. Seven days later, cultures were stained and analyzed for absolute numbers of
DAPICD45+GFP+Thy1.2+CD25+ cells. Data in right-most graph are means and SEMs from each group.
(B) e14.5 Ebf1/ fetal liver LSKs were isolated and cotransducedwithMigY-EBF1 andMigR-ICN1 viruses and plated onOP9 stromal cells. A day later, cells were
washed and replated on OP9s in fresh media supplemented with IL-7, FL, and SCF. On day 7, cultures were stained and analyzed for relative contribution of
DAPICD45+ single-transduced (GFP+YFP or GFPYFP+) or double-transduced (GFP+YFP+) cells that coexpressed Thy1.2 and CD25.
(C) e14.5 Ebf1/ fetal liver LSKs were isolated and cotransduced with MigY-EBF1 and TCF1-VEX viruses as in (B). Plots were gated on DAPICD45+ single- or
double-transduced cells. All graphs show means ± SEMs of triplicate samples. Data are representative of three separate experiments. See also Figure S2.
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Regulation of B Cell Lineage Commitmentprevented T cell development from Ebf1/ and Pax5/ LSKs
transduced with an active allele for Notch1 (ICN1) (Figures 2B
and S2). Likewise, EBF1 prevented T cell differentiation from
progenitors transduced with the Notch1 target Tcf7 (encoding
TCF1) (Figure 2C; Weber et al., 2011). These data indicate that
EBF1 can override T-cell-lineage-promoting signals mediated
by the Notch1-TCF1 pathway and further support the notion
that EBF1 limits cell-intrinsic T cell potential in lymphoid precur-
sors independently of Pax5.
EBF1 Represses the Generation of Gata3 Transcripts
To test whether EBF1 represses the expression of essential T cell
lineage genes, we transduced an Ebf1/ progenitor cell line cor-
responding to pre-pro-B cells with EBF1 (Pongubala et al., 2008)
and analyzed changes in gene expression on Affymetrix microar-
rays. In these experiments, transcripts for Gata3 declined repro-
ducibly, whereasNotch1 and Tcf7 transcript levels as well as the932 Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc.T cell lineage regulator Bcl11b were not altered or increased
slightly (Figure S3A). We repeated these analyses but with quan-
titative RT-PCR and locus-specific probes in Ebf1/ progeni-
tors transduced with virus encoding EBF1 and/or Pax5.
Transduction with EBF1 or Pax5 led to the expected upregula-
tion of transcripts for Igll1 and Vpreb1 encoding components
of the pre-BCR, and cotransduction with EBF1 and Pax5 re-
sulted in a synergistic increase in abundance of these transcripts
(Figure 3A). Consistent with past work (Souabni et al., 2002),
transduction with Pax5 reduced Notch1 transcript abundance
to 50% of controls. Of note, EBF1 transduction did not perturb
Tcf7 transcription substantially and appeared to drive a modest
increase inNotch1 expression that was overridden by coexpres-
sion of Pax5. In sharp contrast, EBF1 transduction consistently
induced an 80% decline in Gata3 transcript abundance (Fig-
ure 3A, top left). Pax5 transduction, by comparison, led to only
a modest reduction inGata3 transcripts, and cells cotransduced
Immunity
Regulation of B Cell Lineage Commitmentwith EBF1 and Pax5 mirrored transduction with EBF1 alone.
Introduction of EBF1 into a Pax5/ pro-B cell line (Schaniel
et al., 2002) also repeatedly resulted in a 50% decline in Gata3
transcripts (Figure 3B), and EBF1 expression continued to pro-
mote the downregulation of Gata3 transcripts in cells cotrans-
duced with ICN1 or TCF1 (Figure 3C).
Next, we analyzed Gata3, Notch1, and Tcf7 transcript abun-
dance in wild-type and Ebf1/ LinCD19IL-7Ra+Flt3+
Sca1loc-KitloB220+ BM lymphoid progenitors subdivided based
on differential Ly6D surface expression (see Figure 1). Remark-
ably, wild-type B220+Ly6D+ progenitors exhibited a 7- to 10-
fold decrease in Gata3 transcripts compared to cells within the
less mature B220+Ly6D fraction (Figure 3D), indicating that
decreasedGata3 expression correlates with loss of T cell lineage
potential. Furthermore, Ebf1/ B220+Ly6D+ precursors ex-
hibited a robust increase in Gata3 transcripts compared to their
wild-type counterparts to levels found in wild-type B220+Ly6D
progenitors. In contrast, we observed only a modest increase in
Notch1, Tcf7 transcripts in B220+Ly6D+ precursors lacking Ebf1.
As expected, expression of the canonical EBF1 target Igll1 was
severely decreased in Ebf1/ B220+Ly6D+ progenitors (Fig-
ure 3D, right-most panel). These data, together with the data in
Figure 1, show that deletion of Ebf1 results in increased Gata3
transcripts and a corresponding increase in T cell lineage poten-
tial in B-cell-lineage-biased lymphoid progenitors, implicating
EBF1-mediated repression of Gata3 as an important event in
early B cell development.
Mechanisms of EBF1-Mediated Gata3 Repression
Given that early B cell development involves collaborative inter-
actions between EBF1 and the E12 and E47 transcription factors
encoded by the Tcf3 gene (Lin et al., 2010; Sigvardsson et al.,
1997), we tested whether EBF1-driven downregulation of
Gata3 mRNA expression required Tcf3-encoded proteins. For
these experiments we employed 4-hydroxytamoxifen (4-OHT)-
responsive fusion proteins consisting of either the E47 or EBF1
coding regions fused to a mutated ligand-binding domain of
estrogen receptor-a (referred to as E47:ER or EBF1:ER, respec-
tively) (Kikuchi et al., 2008; Xu and Kee, 2007). These con-
structs were introduced into Tcf3/ or Ebf1/ progenitors
and routinely resulted in nearly 100% GFP+ cells (not shown).
Notably, whereas induction of E47:ER in Tcf3/ progenitors
led to only a 2-fold decrease in Gata3 transcripts 12 hr later (Fig-
ure S3B), induction of EBF1:ER expression resulted in a 5-fold
decrease in Gata3 mRNA within 12 hr, similar to experiments
with Ebf1/ progenitors (Figure S3C). Moreover, after only
4 hr, induction of EBF1:ER in Tcf3/ progenitors led to a signif-
icant loss in Gata3 transcript abundance (Figure S3C, left). As
expected, in this system induced EBF1:ER caused robust
increases in Igll1 transcripts (Figure S3C, right). These data indi-
cate that silencing of GATA3 expression by EBF1 does not
strictly require E2a proteins.
We also adopted several approaches that together indicate
that EBF1 represses Gata3 expression directly. First, we tested
whether inhibition of protein synthesis with cycloheximide
(CHX) prevents EBF1-driven decreases in Gata3 transcripts.
For these experiments we employed Tcf3/ and Ebf1/ pro-
genitors containing 4-OHT-regulated EBF1:ER. Gata3 downre-
gulation still occurred when transduced Tcf3/ or Ebf1/progenitors were preincubated with CHX for 8 hr before adding
4-OHT (Figure S3D). Likewise, increases in Igll1 transcripts
were also intact in CHX-pretreated cells (Figure S3E). To test
further the possibility that EBF1 mediates silencing of Gata3
indirectly by activating an unknown transcriptional repressor,
we determined whether conversion of EBF1 into an obligate
repressor prevented EBF1-mediated downregulation of Gata3.
To this end we fused the DNA binding domain of EBF1 to
the Drosophila Engrailed repression domain (Fang et al., 2007;
Vickers and Sharrocks, 2002). The resulting EBF1-Engrailed
protein readily repressed transcription of Igll1 when introduced
into Ebf1/ pre-pro-B cells (Figure 4A, left). However, EBF1-
Engrailed continued to decrease transcript abundance for
Gata3 similar to wild-type EBF1 (Figure 4A, right). Together
these data suggest that EBF1 regulates Gata3 mRNA levels
directly.
We utilized the ECR-browser database (http://ecrbrowser.
dcode.org) to determine whether the Gata3 locus contains
conserved EBF1 binding sequences. We noted two such sites
within the Gata3 locus, one upstream of the Gata3 promoter
1b (‘‘site a,’’ 2,350 bases from the transcriptional start site
1b) and a second site within the second intron (‘‘site b,’’
3,290 bases downstream of transcriptional start site 1b) (Fig-
ure S4A). Notably, past data indicate that the intronic regions
of Gata3 play fundamental roles in regulating its expression
(Hwang et al., 2002). We performed ChIP experiments with
EBF1 antibodies and PCR primers flanking either putative
EBF1 binding site (Table S1). Target populations included
CD19+ BM B lineage cells, the Ebf1/ progenitor cell line, and
wild-type CD3ε+ splenic T cells. We observed a 4- to 6-fold
enrichment in EBF1 binding at each site in CD19+ BM cells but
not Ebf1/ progenitors or peripheral T cells (Figure 4B). We
also failed to detect EBF1 binding from a gene desert region
on mouse chromosome 6 in Ebf1/ progenitors and CD19+
BM cells (not shown). In addition, a 24 base pair biotin-labeled
DNA probe encompassing ‘‘site a’’ led to formation of a pro-
tein-DNA complex in electrophoretic mobility shift assays using
nuclear extracts from 293T cells transfected with a His6-tagged
version of EBF1, which was super-shifted by an anti-histidine
antibody. This complex failed to form when we used a probe in
which the putative EBF1 site wasmutated andwas reduced sub-
stantially upon inclusion of an unlabeled wild-type Cd79a probe
containing a canonical EBF1 binding site (Figure S4B). These
data further support a model whereby EBF1 mediates the direct
repression of Gata3 transcription.
To probe the mechanism underlying repression of Gata3, we
tested whether EBF1 promotes epigenetic changes proximal
to EBF1 binding sites associated with transcriptional repression.
First, we explored the possibility that EBF1 promotes DNA
methylation of CpG residues. Though the Gata3 promoter and
second intron both contain prominent CpG islands adjacent to
the EBF1 binding sites (Attema et al., 2007), by sodium bisulfite
sequencing we did not detect changes in the methylation status
of these regions in multipotent lymphoid progenitors versus pro-
B cells (not shown). Because gene silencing can be mediated by
histone modifications independently of DNA methylation (Kondo
et al., 2008), we also evaluated repression-associated histone-
methylation signatures upon ectopic EBF1 expression. We per-
formed ChIP experiments with a H3K27me3-specific antibody,Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc. 933
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Figure 3. EBF1 Represses Gata3 Transcript Levels
(A) Ebf1/ lymphoid progenitors were transduced with MigR1, MiY-EBF1, or Mig-Pax5 virus alone or cotransduced with MiY-EBF1 andMig-Pax5 and plated on
OP9 cells supplemented with IL-7, FL, and SCF. 50,000 DAPIYFP+GFP, YFPGFP+, or YFP+GFP+ cells were sorted 24 hr later for RNA isolation. Transcript
levels of the indicated genes were assayed by qRT-PCR. Expression levels in MigR1-transduced samples were set to 1 and sorted pro-B cells (B220+CD43+
AA4.1+CD19+) were included as an additional control. Error bars indicate SEMs, *p < 0.001.
(B) 23 107 Pax5/ pro-B cells were transduced with control MigR1 or MigR-EBF1 virus and assayed for relative levels ofGata3 transcripts 24 hr later by sorting
on DAPIGFP+ cells as in (A). Starting cell numbers were high due to the refractory nature of these cells to retroviral transduction. Error bars indicate SEMs,
*p < 0.01.
(legend continued on next page)
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trimethylation of H3K27 (Table S1; Barski et al., 2007). CD19+
BM cells were highly enriched for H3K27me3 marks in the
Gata3 locus, although this was not the case for Ebf1/ progen-
itors (Figure 4C). Again, the gene desert region on chromosome 6
was included as an additional negative control (data not shown).
Furthermore, transduction of Ebf1/ progenitors with EBF1
readily induced the acquisition of H3K27me3 marks on chro-
matin surrounding both EBF1 binding sites (Figure 4D). These
data suggest that EBF1 orchestrates epigenetic changes at the
Gata3 locus by directly or indirectly recruiting polycomb (PcG)
group complexes that impart repressive H3K27me3
modifications to this region.
Functional Relevance of Gata3 Repression
We sought to test whether ectopic expression of progenitors
with GATA3 would bypass EBF1-mediated suppression of
T cell differentiation. To this end we cotransduced Ebf1/ pro-
genitors with EBF1 and GATA3 before sorting these cells on
OP9-DL4 cultures. However, consistent with past work indi-
cating that transduction of lymphoid progenitors with GATA3
readily induces apoptosis (Taghon et al., 2007), there was a pro-
gressive decline in viable GATA3-positive cells after transduc-
tion (Figure S5A). We also considered generating transgenic
mice as an alternative approach to achieving increased
GATA3 expression. However, given that Gata3 expression is
regulated by distal enhancer elements (Hosoya-Ohmura et al.,
2011), we concluded that this approach was unlikely to suc-
ceed. Consequently, we tested whether blocking EBF1 binding
to Gata3 regulatory sites prevented EBF1-driven suppression of
early T cell differentiation. Indeed, we reasoned that a failure of
EBF1 to bind to and repress the Gata3 locus should result in
increased Gata3 expression, thereby providing an alternative
approach for increasing GATA3 expression in lymphoid progen-
itors. To this end, we designed a retroviral construct (pMX-
6ZFP) to express a synthetic hexa-modular Zinc-finger protein
(6ZFP) specific for an 18 base region including the last seven
nucleotides of the 8 base core EBF1 binding site between exons
1a and 1b (‘‘site a’’) of the Gata3 locus (Figure S5B). We were
unable to engineer a Zn-finger protein to block binding of
EBF1 to ‘‘site b’’ because of inadequate target site overlap
requirements (see Experimental Procedures). The individual
modular domains of 6ZFP were linked via a polydactyl zinc
finger assembly strategy for recognizing extended sequences
(Gonzalez et al., 2010). The nucleotide and predicted amino
acid sequences for 6ZFP are shown in Table S2. A VP64 tran-
scriptional activation domain was included to counter any po-
tential stalling effect of 6ZFP on endogenous transcription
(Beerli et al., 2000), and a hemagglutinin (HA) tag was added
for assessing 6ZFP binding to particular DNA segments. Control
constructs included retroviruses lacking a polypeptide encoding
insert (pMX) and a second construct encoding an unrelated(C) Ebf1/ pre-pro-B cells were single transduced with Mig-ICN1 or TCF1-VEX o
viruses. Seven days later, RNA was isolated and assayed for relative expression
(D) 50,000 B220+Ly6D or B220+Ly6D+ BM cells were sorted from chimeras est
prepared and qRT-PCR performed as in (A). Expression levels for the indicated g
where B220+Ly6D cells were employed. ND, signal not detected. Data are mean
All data are representative of three separate experiments. See also Figure S3.nonfunctional peptide (pMX-SS). Expression of 6ZFP was
tracked via cotranslation of GFP from an IRES element. Signif-
icantly, after transduction of wild-type LSKs with pMX-6ZFP,
the 6ZFP protein readily occupied ‘‘site a’’ as predicted, but
we were unable to detect occupancy of 6ZFP at ‘‘site b’’ or at
canonical EBF1 binding sites within the Cd79a or Igll1 loci (Fig-
ure 5A). In contrast, pMX-transduced cells failed to exhibit 6ZFP
enrichment at any of these sites.
Pax5/ progenitors were transduced with YFP-marked EBF1
virus and/or one of the aforementioned pMX constructs and
thenculturedonOP9-DL4stromal cells for 7days.As shown (Fig-
ure 5B), whereas EBF1 expression alone led to the expected
reduction in Thy1.2+CD25+ T lineage cells, cotransduction with
EBF1 and pMX-6ZFP but not with EBF1 and either control pMX
constructs restored numbers of T lineage cells to 50% of that
observed in cells transduced with pMX-6ZFP alone (pMX-SS
data not shown). As expected, 6ZFPexpression led to decreased
enrichment for EBF1 between exons 1a and 1b without affecting
EBF1 binding between exons 2 and 3 (Figure 5C). Moreover,
cotransduction with pMX-6ZFP and EBF1 restored Gata3
mRNA levels to 50% of EBF1-transduced cells (Figure 5D), and
pMX-6ZFP expression alone increased Gata3 mRNA levels
2-fold compared to cells transduced with pMX (not shown).
Notably, the increased levels of Gata3 induced with 6ZFP
expression correlated with decreased differentiation of B220+
CD19+ B lineage cells from wild-type fetal liver cells cotrans-
duced with EBF1 (Figure 6A), suggesting that elevated Gata3
mRNA levels, in part due to reduced EBF1 occupancy within
‘‘site a,’’ perturbed early B cell development. To test this hypo-
thesis directly, we introduced pMX or pMX-6ZFP into BM
LSKs and CLPs sorted from either VavCre transgenics or VavCre
Gata3fl/fl mice and then sorted GFP+ cells from these cultures
onto OP9 stromal cells. Strikingly, although 6ZFP prevented
B cell differentiation when introduced into GATA3-competent
lymphoid progenitors, early B cell differentiation was restored
upon deletion of Gata3 (Figure 6B). Altogether these findings
indicate that direct EBF1-mediated repression of Gata3 tran-
scription is critical for extinguishing T cell lineage choice and
allowing lymphoid progenitors to adopt the B cell fate.
Repression of GATA3 in T-Lineage-Committed Cells
Finally, to probe whether EBF1 can repress Gata3 in T-lineage-
committed cells, we assessed whether survival of GATA3-
dependent Tcf3/ 1.F9 thymoma cells (Xu and Kee, 2007) is
perturbed upon introducing EBF1. Transduction of 1.F9 cells
with EBF1 led to a 5-fold reduction of Gata3 transcript abun-
dance in these cells (Figure S6A). Whereas control virus did
not affect viability over 8 days, introducing EBF1 decreased
cell viability to less than 20%within 4 days (Figure S6B). Consis-
tent with past data (Xu and Kee, 2007), loss of viability correlated
with accumulation of the active form of proapoptotic caspase 3
(Figures S6C). Moreover, both cell death and active caspase 3r cotransduced with MigY-EBF1 and MigR-ICN1 or MigY-EBF1 and TCF1-VEX
of Gata3 transcripts as in (A).
ablished with WT or Ebf1/ fetal liver progenitors as in Figure 1A. cDNA was
enes in WT B220+Ly6D+ cells were arbitrarily set to 1, except for Igll1 detection
s ± SEMs of triplicate samples. Error bars indicate SEMs, *p < 0.001, **p < 0.01.
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Figure 4. EBF1 Binds to the Gata3 Locus and Induces Repressive Histone Modifications
(A) Ebf1/ lymphoid progenitors were transducedwith a construct encoding an EBF1-Engrailed fusion protein, wild-type EBF1, or control virus. After 12 hr, GFP+
cells were harvested, cDNA prepared, and Igll1 orGata3mRNA levels determinedwith Taqman primer-probe sets. The data are normalized to transcript levels for
either Igll1 or Gata3 in cells transduced with MigR1 control virus.
(B) ChIP via anti-EBF1 was performedwith the indicated cell types including CD19+ BM lymphocytes andCD3ε+ thymocytes. qRT-PCRwas performed to amplify
immunoprecipitated DNA with flanking primers to sites a or b; detection signals were normalized to input DNA. Data are expressed as fold enrichment over
Ebf1/ cells, which served as negative control.
(C) H3K27me3 modifications within sites 1–5 in CD19+ BM lymphocytes relative to Ebf1/ cells.
(D) Ebf1/ cells were transduced with control MigR1 or MigR-EBF1 virus and plated on OP9 cells in presence of IL-7, FL, and SCF. 24 hr later, DAPIGFP+ cells
were sorted, fixed, and processed for ChIP. Relative H3K27me3 enrichment at sites 1–5 in EBF1 versus control-transduced samples is shown. Data are means ±
SEMs of triplicate samples. Error bars indicate SEMs, *p < 0.01, **p < 0.001. Data are representative of four separate experiments.
See also Figures S3 and S4 and Table S1.
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Figure 5. Inhibition of EBF1 Binding to the Gata3 Locus Rescues T Cell Differentiation
(A) ChIP experiments with HA antibodies were performed on GFP+ progenitors transduced 7 days previously with pMX-6ZFP or pMX (control) by site-specific
PCR primers.
(B) Sorted e14.5 Pax5/ fetal liver LSKs were cotransduced with pMX-ZF and MigY-EBF1 viruses and then added to OP9 stromal cells. pMX and MigY-EBF1
cotransduced cells served as control. After 24 hr, cells were washed and replated on OP9-DL4 stromal cells in fresh media supplemented with IL-7, FL, and SCF.
On day 7, cultures were stained and analyzed for frequencies of Thy1.2+CD25+ cells among DAPICD45+ single- or double-transduced cells.
(C) Sorted e14.5 Ebf1/ fetal liver LSKs were cotransduced with pMX and MigY-EBF1 or pMX-ZF and MigY-EBF1 viruses, added to OP9 stromal cells. After
7 days, viable YFP+GFP+ cells were sorted, fixed, and subjected to ChIP with either EBF1 or HA antibodies. Relative enrichment of EBF1 versus 6ZFP in
transduced Ebf1/ cells at ‘‘site a’’ is shown, with ChIP results for ‘‘site b’’ included as controls for EBF1 and 6ZFP occupancy. Data are expressed as fold
enrichment over nontransduced Ebf1/ cells.
(D) Single- or double-transduced cells from pMX and MigY-EBF1 transduced samples as well as pMX-ZF and MigY-EBF1 transduced samples were sorted for
RNA 24 hr after infection and analyzed for relative expression of Gata3 by qRT-PCR. Data are means ± SEMs of triplicate samples. Error bars indicate SEMs,
*p < 0.001. Data are representative of two separate experiments.
See also Figure S5 and Table S2.
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and GATA3 in 1.F9 cells (Figures S6D and S6E). These data
further support a model whereby EBF1 constrains T cell differen-tiation by silencing Gata3 expression and further suggest that
EBF1 may limit T cell development by perturbing GATA3-
dependent survival mechanisms.Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc. 937
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Figure 6. Decreased GATA3 Expression Is Essential for Early B Cell Development
(A) Sorted e14.5 WT fetal liver LSKs were transduced with only pMX-6ZFP or MigY-EBF1 or both viruses, plated on OP9s, and analyzed for frequencies of viable
B220+CD19+ cells on day 7. Double-transduced cells were identified as viable (DAPI) GFP+YFP+ cells.
(B) Sorted CD45B6+Flt3+ LSKs and CLPs from B6.CD45SJL adults previously reconstituted with BM cells from C57BL/6 (CD45B6) backcrossed VavCre or VavCre
Gata3fl/fl mice were transduced with pMX or pMX-6ZFP. Equal numbers of GFP+ cells were sorted into triplicate cytokine supplemented OP9 stromal cultures,
and B cell differentiation was assessed 7 days later. Graphical data are means ± SEMs of triplicate samples.
p < 0.001.
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Our results provide insights into the transcriptional circuitry
responsible for generating early B-cell-lineage-restricted pre-
cursors. Whereas deletion of Ebf1 in B-cell-lineage-biased
lymphoid progenitors catalyzed an increase in Gata3 transcript
abundance concurrent with a rejuvenation in their T cell poten-
tial, enforcing EBF1 repressed T cell differentiation and Gata3
mRNA levels, even in Pax5-deficient progenitors and despite
ectopic Notch1 and TCF1 activity. Perhapsmost notably, pertur-
bation of EBF1 binding at a Gata3 regulatory region interfered
with EBF1-driven suppression of early T cell differentiation,
concomitantly preventing B cell differentiation due to increased
Gata3 expression.
EBF1 is an indispensible component of the transcriptional
regulatory framework required for generating pro-B cells. Within
this network of transcription factors, E2a proteins activate the
expression of Ebf1 and Foxo1, and subsequently EBF1 works
in concert with E12 and E47 and Foxo1 to promote Pax5 expres-
sion (Lin et al., 2010). Although these previous studies demon-938 Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc.strate synergism between these transcription factors to activate
certain key B-cell-specific molecules, they also raise questions
about how specific components of this network might collabo-
rate to constrain alternative fates. Because Pax5 is essential
for establishing and maintaining B cell identity (Cobaleda et al.,
2007; Mikkola et al., 2002), one view would be that B cell lineage
restriction is mediated chiefly and perhaps exclusively by Pax5.
However, our results highlight the ability of EBF1 to suppress
T cell differentiation of Pax5-deficient progenitors without an
immediate decline in Notch1 transcripts. Furthermore, unlike
many genes that are upregulated by EBF1, our data suggest
that EBF1 represses Gata3 transcription without input from
E2a proteins. Therefore, we propose that B cell lineage restric-
tion is controlled by two or more separate transcriptional path-
ways, with Pax5 and EBF1 repressing Notch1 and Gata3
expression, respectively. Moreover, in light of past data indi-
cating that E2a proteins are unique among B cell regulatory tran-
scription factors in their ability to repress erythroid differentiation
(Ikawa et al., 2004), B cell lineage commitment may be faci-
litated by a variety of transcriptional and temporally distinct
Immunity
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and perhaps myeloid potentials as lymphoid-biased progenitors
develop, EBF1 would silence T cell potential as well as residual
myeloid potentials during adoption of the B cell fate, and Pax5
would silence alternative fates after the generation of pro-B cells.
This viewpoint is consistent with recent data suggesting that
suppression of alternative fates during T cell commitment also
requires the activity of multiple transcriptional pathways (Zhang
et al., 2012). Further work, including an evaluation of the potential
role played by EBF1 in maintaining mature B cell identity and the
role of other transcriptional regulators and cofactors in this pro-
cess, may shed additional light on whether maintenance of the B
cell fate also requires input from multiple transcription factors.
Although the role of GATA3 in peripheral T cell differentiation
has been studied intensively (Amsen et al., 2007; Fang et al.,
2007), recent studies together with our findings emphasize the
essential role played by GATA3 in very early stages of T cell
development. In the thymus, Notch1 signaling in early T lineage
cells induces the expression of additional regulators including
Hes1 and Tcf7. In turn, TCF1 promotes the expression of
numerous genes required for T cell development and function
(Weber et al., 2011), but Tcf7-deficientmice continue to generate
T cells, albeit with decreased numbers (Schilham et al., 1998). By
contrast, Gata3-deficient progenitors fail to generate T lineage
cells beyond the ETP stage of early thymocyte development
(Hendriks et al., 1999; Taghon et al., 2007). Indeed, recent data
suggest that GATA3 activity may be essential for optimal Notch1
expression in ETPs, as shown by the fact that GATA3 binds to
the Notch1 promoter in early thymocytes and that deletion of
Gata3 in thymocytes reduces Notch1 transcripts (Wei et al.,
2011). Moreover, GATA3 occupies distinct sets of regulatory re-
gions at different stages of thymocyte development (Zhang et al.,
2012), suggesting that GATA3 regulatesmany diverse aspects of
T cell development downstream of Notch1 activation. The latter
viewpoint is supported by our data showing that EBF1 prevents
T cell differentiation despite ectopic Notch1 activity or enforced
TCF1 expression. Altogether, these collective observations indi-
cate that Gata3 constitutes a prime target for regulatory path-
ways that silence the T cell fate in early B lineage cells.
The mechanisms governing transcriptional activation of EBF1
target genes have been studied intensively (Hagman et al., 1995;
Maier et al., 2004; Sigvardsson et al., 2002). By contrast, how
EBF1 represses transcription of certain loci is only beginning to
be addressed (Gao et al., 2009). Recent analyses of EBF1 occu-
pancy of genes across the B cell genome suggest that the vast
majority of EBF1 targets are located in transcriptionally active
regions (Treiber et al., 2010). Therefore, the default mode for
EBF1 may be as a transcriptional activator. However, other
EBF1 target loci were found in transcriptionally inactive regions,
and EBF1 has also been shown to downregulate the expression
of the E-protein regulators Id2 and Id3 (Thal et al., 2009). There-
fore, EBF1 may repress additional important loci during estab-
lishment and maintenance of the B cell fate.
The use of synthetic Zn fingers such as our 6ZFP construct to
evaluate the role of defined cis elements may prove useful in
studying other region-specific protein-DNA interactions in a
wide variety of biological and experimental contexts. However,
interpretation of data derived from this approach could be
confounded by off-target DNA binding events. Here, 6ZFP didnot appear to bind to alternative EBF1 binding sites within the
Gata3, CD79a, or Igll1 locus and led to the predicted outcomes
in Gata3 mRNA levels and T and B cell differentiation. Nonethe-
less, 6ZFPmay bind to additional undefined elements across the
genome. We considered performing ChIP-seq experiments to
determine the identity of these alternative elements, but we sus-
pect strongly that the functional relevance of these sites would
be obscure at best. Indeed, recent genome-wide analyses of
DNA occupancy by EBF1 suggest that endogenous transcription
factors may also bind to a wide range of elements with unknown
functional relevance (Treiber et al., 2010). Therefore, although
synthetic proteins containing six tandem Zn fingers such as
6ZFP may prove to possess minimal off-target effects (Gabriel
et al., 2011), validating the specificity of such proteins with a
particular biological outcome may require the use of cells
bearing appropriate mutations.
Finally, although the precise molecular details remain unclear,
we hypothesize that the switch between activator and repressor
functions of EBF1 at different loci reflects differential spatio-
temporal interactions of EBF1 with coactivator and corepressor
complexes, which in turn would be dictated by diverse proximal
and/or distal cis elements. Our results show that EBF1 binding
within the Gata3 locus is associated with repressive
H3K27me3 marks on nearby chromatin. These results implicate
EBF1 in the active recruitment of polycomb group (PcG) re-
pressor complexes. Currently the chief mediator of H3K27me3
modifications in eukaryotes is the protein enhancer of zeste 2
(Ezh2), a member of the polycomb repressor complex 2
(PRC2) (Cao and Zhang, 2004). PRC2 activity in turn attracts
PRC1, which prevents transcriptional initiation by RNA polymer-
ase II (Dellino et al., 2004). Therefore, it is tempting to suggest
that EBF1 binding at theGata3 locus directly or indirectly initiates
mobilization of PRC2 complexes to this region, thereby blocking
interactions with coactivators and stabilizing chromatin modifi-
cations associated with long-term transcriptional silencing.
Assuming that this sequence of events is indeed contingent on
sequence-specific corepressors, competitive blockade of their
cognate DNA sites via our Zn-finger protein strategy might
neutralize repressive effects of EBF1 at theGata3 locus. Further-
more, given that histonemodification is a dynamic and reversible
process (Tagoh et al., 2004; Zhang et al., 2012), it will be informa-
tive to test whether induced deletion of EBF1 in B-lineage-
committed cells causes the reversal of trimethylation on H3K27
residues in Gata3 regulatory regions, possibly leading to Gata3
expression. The consequences of such aberrant expression
would give us further clues into the biological significance of
Gata3 silencing in B cells.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6.Ly5SJL females (6–8 weeks of age) were from the NCI
animal facility (Frederick, MD). Ebf1+/ mice were kindly provided by B. Kee
(University of Chicago) with permission from R. Grosschedl (Max Planck
Institute, Freiburg). Pax5+/ mice were kindly provided by M. Busslinger
(Research Institute of Molecular Pathology, Vienna). Gata3fl/fl and VaviCre
mice were kindly provided by J. Zhu (National Institutes of Health) and
D. Kioussi (National Institute for Medical Research, London), respectively. All
animal experiments were performed according to protocols approved by the
Office of Regulatory Affairs of the University of Pennsylvania in accordanceImmunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc. 939
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Regulation of B Cell Lineage Commitmentwith guidelines set forth by NIH and by the local ethics committee at the
University of Oxford and the United Kingdom Home Office.
Cell Culture
Primary progenitors and progenitor cell lines were cultured as described pre-
viously (Pongubala et al., 2008; Xu and Kee, 2007). Details are provided in the
Supplemental Information.
Plasmids
A detailed description of all retroviral plasmids is available in the Supplemental
Information. For expression of synthetic Zn-finger polypeptides, the predicted
6ZFP mini-gene sequence was synthesized by Blue Heron Biotech, cloned
into the control pMX-VP64-IRES-GFP retroviral construct (C. Barbas, Scripps
Research Institute), and renamed pMX-6ZFP. A plasmid eliciting translation of
an unrelated nonfunctional peptide (pMX-SS) was also provided by the Barbas
lab. A nuclear localization signal sequence (NLS) and hemagglutinin (HA) tag
are also included in the pMX vector backbone.
Flow Cytometry
Stained single-cell suspensions were stained and analyzed as described pre-
viously (Pongubala et al., 2008). Details of antibodies and flow cytometers
used are available in the Supplemental Information.
Generation of Fetal Liver Chimeras
B6.Ly5SJL hosts were irradiated (900R) 6 hr before intravenous transfer of day
14.5 fetal liver cells isolated from B6 or Pax5/ or Ebf1/ embryos.
T Lymphoid Differentiation Assays
Bulk and clonal assays measuring T cell differentiation were performed with
OP9-DL4 stromal cells as described previously (Weber et al., 2011) and in
the Supplemental Information.
Retroviral Transduction
High-titer virus was generated by a CaPO4 transfection protocol (Pear et al.,
1993). Cultures were supplemented with fresh medium at 12 hr after infection
and harvested for downstream applications at indicated time points after
infection.
Gene Expression Analyses
For quantitative RT-PCR, RNA was purified from indicated cell types with the
QIAGEN RNeasy Mini Kit and reverse transcribed to cDNA with GE first-strand
cDNA synthesis kit. Real-time PCR was performed with inventoried TaqMan
probes for indicated genes and analyzed on an ABI Prism 7300 system
(Applied Biosystems). 18S rRNA served as endogenous control for all
samples. Relative transcript abundance was determined with the DDCt
method. Microarray analyses are described in the Supplemental Information.
Chromatin Immunoprecipitation Assays
CD3ε+ thymocytes and CD19+ BM cells were column selected (Miltenyi
Biotec). In case of control vector and EBF1-transduced Ebf1/ cells or cells
cotransduced with EBF1 and pMX/pMX-6ZFP/pMX-SS viruses, viable GFP+
or YFP+GFP+ cells were sorted either 24 hr or 7 days after infection as indi-
cated. ChIP was performed on indicated cell types (2 3 106 cells/assay) with
the ChIP-IT kit (Active Motif). In brief, cells were fixed for 10 min at room
temperature with 1% formaldehyde, treated with glycine stop-fix solution,
then lysed with dounce-homogenizer. Pelleted nuclei were digested in pres-
ence of protease inhibitor cocktail and chromatin was enzymatically sheared.
Sheared chromatin was immunoprecipitated with 4 mg anti-EBF1 (a kind gift
from R. Grosschedl) or anti-H3K27me3 (07-449, Millipore) or anti-HA
(ab9110, Abcam). After washing, bound chromatin was eluted and treated
for reversal of crosslinking. After proteinase K digestion, DNAwas immediately
used in quantitative real-time PCR (SYBR Green, ABI). PCR primer sets are
outlined in Table S1. A negative control primer set (Active Motif, catalog
number 71011) for an 82 base pair gene desert region on mouse chromosome
6 was included in each immunoprecipitation. Nonenrichment for EBF1 or
anti-H3K27me3 at this site served as a ChIP specificity control.940 Immunity 38, 930–942, May 23, 2013 ª2013 Elsevier Inc.Zinc Finger Protein Design
A 48 base pair (bp) sequence spanning the EBF1 binding ‘‘site a’’ (as confirmed
by ChIP assays) in Gata3 genomic locus was selected. Using the publicly
available online resource called Zinc Finger Tools (http://www.scripps.edu/
mb/barbas/zfdesign/zfdesignhome.php), an 18 bp potential target site
including the EBF1 binding site was identified and the amino acid sequence
of a hexa-modular zinc finger protein (6ZFP) predicted to bind to this site
was designed (Table S2). Because of unmet target site overlap requirements,
designing 6ZFP for a target site covering the intronic EBF1 binding ‘‘site b’’ was
avoided as recommended (Mandell and Barbas, 2006).
Statistical Analysis
Themeans of each data set were analyzed by Student’s t test, with a two-tailed
distribution assuming equal sample variance.ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE46004.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.01.014.
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